Papers
2
Total Citations
12
H-Index
1
About
Yu Katayose is a leading figure in hepatobiliary and pancreatic surgery, with a focused expertise in the surgical management of biliary tract diseases and congenital anomalies. His early work on minimally invasive techniques is exemplified by his 2015 study on robotic surgery for type I congenital dilatation of the bile duct, which has garnered 11 citations and helped establish the safety and feasibility of robotic approaches in complex pediatric and adult biliary reconstructions. More recently, Katayose has contributed to the evolving landscape of biliary tract cancer (BTC) treatment, offering a comprehensive 2025 review that synthesizes current insights and future therapeutic strategies. This work underscores the persistent challenges in BTC, including high perioperative mortality in hilar cholangiocarcinoma and gallbladder cancer, while highlighting the need for tailored surgical and multimodal approaches. His research bridges the gap between advanced surgical innovation and the pressing clinical realities of rare, aggressive tumors. Katayose’s contributions continue to shape best practices in hepatobiliary surgery, making him a valuable voice for surgeons and oncologists seeking to improve outcomes in these difficult disease contexts.
Research Focus
Key Achievements
Top Papers
- 1
- 2